Alumis Inc (ALMS) Growth Rates Comparisons to Major Pharmaceutical Preparations Industry, Sector, Market. Sales, Income, EPS
CSIMarket
 
Alumis inc   (NASDAQ: ALMS)
 

Alumis Inc Growth Comparisons

Select each growth Category to receive further Information





ALMS Revenue Growth Rate Comparisons Company Industry Sector S&P 500
Y / Y Revenue Growth (Q1 MRQ) -89.99 % 13.2 % 12.44 % 10.9 %
Q / Q Revenue Growth (Q1 MRQ) -9.75 % -2.93 % -5.89 % 8.32 %
Y / Y Revenue Growth (for 12 months ending Q1 TTM) -51.68 % 9.56 % 8.1 % %
Sequential Revenue Growth (for 12 months ending Q1 TTM) -65.06 % 2.84 % 2.11 % 2.61 %
Revenue 5 Year Average Growth - 8.75 % 9.34 % 13.48 %


ALMS's Growth Comparisons in I. Quarter 2026




As Alumis Inc 's sales faded by -89.99% year on year in the first quarter 2026, the Major Pharmaceutical Preparations industry grew by 13.2%, Alumis Inc 's first quarter 2026 performance was trailing the Major Pharmaceutical Preparations industry in the first quarter 2026, and underperformed the 12.44% Revenue improvement in the Healthcare sector. Although both Major Pharmaceutical Preparations industry and Healthcare sector posted higher gains than 10.9% overall market increase, Alumis Inc was trailing overall market in the first quarter.

Top-line fell by -9.75% from the fourth quarter. Average annual sales growth for Alumis Inc is %, while S & P 500's average yearly sales increase is 13.48%, including only Businesses with the first quarter 2026 financial results.

ALMS Growth Rates by Company's Segments

Segment Name
Y / Y
Sequential
Collaboration
-
-
Single reportable segment
-89.99 %
-
Single reportable Collaboration
-
-
Total
-89.99 %
-92.76 %


Growth Rates of ALMS's Income in the first quarter 2026


ALMS Operating Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Operating Income Change (Q1 MRQ) - -8.88 % 4.02 % 97.6 %
Sequential Operating Income Change (Q1 MRQ) - -4.51 % 0.66 % 48.13 %
Y / Y Operating Income Growth (Q1 TTM) - 31.15 % 25.59 % 40.67 %
Sequential Operating Income Growth (Q1 TTM) - -2.06 % -0.04 % 20.86 %
Operating Income 5 Year Avg. Change - 14.98 % 10.62 % 28.66 %


Income from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Income from Cont. Ops. Change (Q1 MRQ) - -34.9 % -27.62 % 90.69 %
Sequential Income from Cont. Ops. Change (Q1 MRQ) - -2.6 % -67.3 % 27.07 %
Y / Y Income from Cont. Ops. Change (Q1 TTM) - 6.72 % 2.09 % 57.33 %
Sequential Income from Cont. Ops. Change (Q1 TTM) - -9.75 % -5.05 % 18.65 %
Income from Cont. Ops. 5 Year Avg. Change - 14.8 % 8.95 % -24.17 %

ALMS Net Income Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y Net Income Growth (Q1 MRQ) - -35.09 % -27.58 % 90.69 %
Q / Q Net Income Growth (Q1 MRQ) - 2.88 % -2.01 % 27.07 %
Y / Y Net Income Change (Q1 TTM) - 5.24 % 16.23 % 57.33 %
Sequential Net Income Change (Q1 TTM) - -9.87 % -6.91 % 18.65 %
Net Income 5 Year Avg. Growth - 14.99 % 9.41 % 30.75 %

ALMS's EPS Growth Rates


EPS from Cont. Ops. Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS from Cont. Ops. Change (Q1 MRQ) - -40.26 % -27.62 % 90.69 %
Sequential EPS from Cont. Ops. Change (Q1 MRQ) - -7.71 % -67.3 % 27.07 %
Y / Y EPS from Cont. Ops. Change (Q1 TTM) - - - -
Sequential EPS from Cont. Ops. Change (Q1 TTM) - - - 4.88 %
EPS from Cont. Ops. 5 Year Avg. Growth - 2.03 % 8.95 % -24.17 %



ALMS EPS Net Growth Rates Comparisons Company Industry Sector S&P 500
Y / Y EPS Net Growth (Q1 MRQ) - -40.44 % -27.58 % -24.17 %
Q / Q EPS Net Growth (Q1 MRQ) - -2.51 % -2.01 % 27.07 %
Y / Y EPS Net Change (for 12 months ending Q1 TTM) - - - 7.62 %
Sequential EPS Net Change (for 12 months ending Q1 TTM) - - - 4.93 %
EPS Net 5 Year Avg. Change - 14.99 % 9.41 % 30.75 %



Alumis Inc reported bottom-line of $ -0.74 in the first quarter, compare to $ -1.82 in the same quarter a year ago. Major Pharmaceutical Preparations industry fell by -40.44%, while Healthcare sector decreased by -27.58%, and overall market improved by 90.69%.

the bottom-line fell by -9.75% from the fourth quarter. Average annual income per share growth for Alumis Inc is %, while S & P 500's average yearly income per share increase is 30.75%, including only Businesses with the first quarter 2026 earnings.

ALMS Cash Flow Growth Rates


Free Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Free Cash Flow Change (Q1 MRQ) - 25.56 % 56.23 % 48.62 %
Sequential Free Cash Flow Change (Q1 MRQ) - -43.31 % -49.65 % 34.18 %
Y / Y Free Cash Flow Change (Q1 TTM) - 13.44 % 23.71 % 60.27 %
Sequential Free Cash Flow Change (Q1 TTM) - 4.56 % 6.17 % 15.75 %
Free Cash Flow 5 Year Avg. Change - 3.5 % 1.82 % 18.38 %

Net Cash Flow Growth Rates Company Industry Sector S&P 500
Y / Y Net Cash Flow Change (Q1 MRQ) - - - 339.02 %
Sequential Net Cash Flow Change (Q1 MRQ) - - - 216.68 %
Y / Y Net Cash Flow Change (Q1 TTM) - - - 209.43 %
Sequential Net Cash Flow Change (Q1 TTM) - - - 152.64 %
Net Cash Flow 5 Year Avg. Change - 29.18 % 6.07 % 4.29 %

Capital Expenditures Company Industry Sector S&P 500
Y / Y Capital Expenditures Change (Q1 MRQ) 343.24 % 11.16 % 8.1 % 120.03 %
Sequential Capital Expenditures Change (Q1 MRQ) - -22.14 % -19.56 % 36.87 %
Y / Y Capital Expenditures Change (Q1 TTM) -55.91 % 16.93 % 6.71 % 109.38 %
Sequential Capital Expenditures Change (Q1 TTM) 19.45 % 3.01 % 1.65 % 23.05 %
Capital Expenditures 5 Year Avg. Change - 7.04 % 7.13 % 10.69 %

Note
To view Detail Information & Trends click on Individual Category.
To see Industry, Sector or S&P 500 Performance, click on each Category respectivly, on the top of the Table.

For explanation of terms visit: Glossary
 







Help

About us

Products

Data downloads

API

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research.

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com

Disclaimer: Information provided by CSIMarket.com is for informational purposes only and does not constitute investment advice, recommendation, or solicitation to buy or sell any security.

© 2026 CSIMarket.com — Proprietary financial dataset. All rights reserved. Redistribution or automated extraction prohibited.